MX337593B - Gemcabeno y derivados para tratar la pancreatitis. - Google Patents

Gemcabeno y derivados para tratar la pancreatitis.

Info

Publication number
MX337593B
MX337593B MX2013007310A MX2013007310A MX337593B MX 337593 B MX337593 B MX 337593B MX 2013007310 A MX2013007310 A MX 2013007310A MX 2013007310 A MX2013007310 A MX 2013007310A MX 337593 B MX337593 B MX 337593B
Authority
MX
Mexico
Prior art keywords
gemcabene
derivatives
treating pancreatitis
pancreatitis
free acid
Prior art date
Application number
MX2013007310A
Other languages
English (en)
Spanish (es)
Other versions
MX2013007310A (es
Inventor
Charles L Bisgaier
Original Assignee
Michigan Life Therapeutics Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Michigan Life Therapeutics Llc filed Critical Michigan Life Therapeutics Llc
Publication of MX2013007310A publication Critical patent/MX2013007310A/es
Publication of MX337593B publication Critical patent/MX337593B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/06Antihyperlipidemics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2013007310A 2010-12-27 2011-12-22 Gemcabeno y derivados para tratar la pancreatitis. MX337593B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201061427236P 2010-12-27 2010-12-27
PCT/US2011/066736 WO2012092103A1 (fr) 2010-12-27 2011-12-22 Gemcabène et dérivés pour le traitement de la pancréatite

Publications (2)

Publication Number Publication Date
MX2013007310A MX2013007310A (es) 2013-10-25
MX337593B true MX337593B (es) 2016-03-11

Family

ID=45498140

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013007310A MX337593B (es) 2010-12-27 2011-12-22 Gemcabeno y derivados para tratar la pancreatitis.

Country Status (14)

Country Link
US (1) US8846761B2 (fr)
EP (2) EP2658536B1 (fr)
JP (3) JP2014509305A (fr)
CN (2) CN103442707A (fr)
AU (1) AU2011352449B2 (fr)
CA (1) CA2822921C (fr)
DK (1) DK2658536T3 (fr)
ES (1) ES2608177T3 (fr)
HK (1) HK1250484A1 (fr)
HU (1) HUE031004T2 (fr)
MX (1) MX337593B (fr)
PL (1) PL2658536T3 (fr)
PT (1) PT2658536T (fr)
WO (1) WO2012092103A1 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2017533973A (ja) 2014-11-14 2017-11-16 ジェムフィアー セラピューティクス インコーポレイテッド α,ω−ジカルボン酸末端ジアルカンエーテルを調製するためのプロセスおよび中間体
AU2016348638A1 (en) * 2015-11-06 2018-06-07 Gemphire Therapeutics Inc. Gemcabene combinations for the treatment of cardiovascular disease

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1989011852A1 (fr) * 1988-06-06 1989-12-14 Showa Denko Kabushiki Kaisha Agent de traitement de la pancreatite ou similaire
US5648387A (en) 1995-03-24 1997-07-15 Warner-Lambert Company Carboxyalkylethers, formulations, and treatment of vascular diseases
US20020103252A1 (en) 1997-12-12 2002-08-01 Bisgaier Charles Larry Statin-carboxyalkylether combinations
US6861555B2 (en) 2000-01-25 2005-03-01 Warner-Lambert Company Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith
US20030105154A1 (en) * 2001-10-24 2003-06-05 Bisgaier Charles Larry Statin-carboxyalkylether combinations
WO2000059855A1 (fr) 1999-04-01 2000-10-12 Esperion Therapeutics, Inc. Composes d'ether, compositions et leurs utilisations
EP1351916A2 (fr) * 2000-10-11 2003-10-15 Esperion Therapeutics Inc. Composes d'ether et compositions pour la gestion du cholesterol et utilisations associees
US6645170B2 (en) 2001-03-05 2003-11-11 Bioject Medical Technologies, Inc. Simplified disposable needle-free injection apparatus and method
US20040229954A1 (en) * 2003-05-16 2004-11-18 Macdougall Diane Elaine Selective manipulation of triglyceride, HDL and LDL parameters with 6-(5-carboxy-5-methyl-hexyloxy)-2,2-dimethylhexanoic acid monocalcium salt
US7345190B2 (en) 2003-11-12 2008-03-18 Ssv Therapeutics, Inc. Carnitine conjugates as dual prodrugs and uses thereof

Also Published As

Publication number Publication date
US20120165411A1 (en) 2012-06-28
PT2658536T (pt) 2016-12-22
HUE031004T2 (en) 2017-06-28
CN103442707A (zh) 2013-12-11
HK1250484A1 (zh) 2018-12-21
AU2011352449B2 (en) 2015-06-18
EP2658536A1 (fr) 2013-11-06
WO2012092103A1 (fr) 2012-07-05
EP3170495B1 (fr) 2023-04-26
CA2822921A1 (fr) 2012-07-05
CN107648210A (zh) 2018-02-02
ES2608177T3 (es) 2017-04-06
JP2014509305A (ja) 2014-04-17
EP3170495A1 (fr) 2017-05-24
DK2658536T3 (en) 2017-01-09
JP6207560B2 (ja) 2017-10-04
MX2013007310A (es) 2013-10-25
CA2822921C (fr) 2018-07-17
JP2018027953A (ja) 2018-02-22
AU2011352449A1 (en) 2013-07-11
PL2658536T3 (pl) 2017-04-28
EP2658536B1 (fr) 2016-10-19
JP2016028075A (ja) 2016-02-25
US8846761B2 (en) 2014-09-30

Similar Documents

Publication Publication Date Title
PH12015501404B1 (en) Neuroactive 19-alkoxy-17-substituted steroids, prodrugs thereof, and methods of treatment using same
WO2011113013A3 (fr) Procédés et compositions pour le traitement d'états viraux ou induits par des virus
UA115139C2 (uk) Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
NZ732507A (en) Improved compositions for treating muscular dystrophy
GB2491328A (en) Immediate/delayed drug delivery
IN2014KN00996A (fr)
PH12016502355B1 (en) Pharmaceutical composition
MX2022010507A (es) Metodos para reducir riesgo de evento cardiovascular en sujeto con terapia con estatina.
MX2019007956A (es) Liberacion autorregulada de ingrediente farmaceutico activo.
MX2011008448A (es) Uso de ester etilico del acido eisosapentaenoico para tratar hipertrigliceridemia.
MX2014002171A (es) Tratamientos de combinacion para hepatitis c.
MY160249A (en) Fatty acid fumarate derivatives and their uses
NZ714963A (en) Compositions and methods for treating anemia
MY173215A (en) Acetylcysteine compositions and methods of use thereof
IN2015DN04175A (fr)
BR112012031297A2 (pt) formulações de spray oral e métodos para administração de sildenafil
MX364220B (es) Metodos de tratamientos de fibrosis.
MX362830B (es) Agente terapeutico o profilactico para enfermedades del tracto biliar.
MX2014002480A (es) Uso del compuesto organico para el tratamiento del sindrome de noonan.
IN2014DN00123A (fr)
MX337593B (es) Gemcabeno y derivados para tratar la pancreatitis.
MX2015007945A (es) Usos y métodos para el tratamiento de enfermedades o afecciones hepáticas.
MX2014014814A (es) Composicion farmaceutica para el tratamiento de inflamacion y dolor.
TW201129361A (en) Methods for treating pain
UA74544U (ru) Способ лечения и профилактики хронического генерализованного пародонтита

Legal Events

Date Code Title Description
FG Grant or registration